- Home
- REPL vs SCVL Comparison
REPL vs SCVL Comparison
Compare REPL & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- SCVL
- Stock Information
- Founded
- REPL 2015
- SCVL 1978
- Country
- REPL United States
- SCVL United States
- Employees
- REPL N/A
- SCVL N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- SCVL Clothing/Shoe/Accessory Stores
- Sector
- REPL Health Care
- SCVL Consumer Discretionary
- Exchange
- REPL Nasdaq
- SCVL Nasdaq
- Market Cap
- REPL 547.0M
- SCVL 608.5M
- IPO Year
- REPL 2018
- SCVL 1993
- Fundamental
- Price
- REPL $9.73
- SCVL $18.33
- Analyst Decision
- REPL Buy
- SCVL Hold
- Analyst Count
- REPL 9
- SCVL 1
- Target Price
- REPL $10.88
- SCVL N/A
- AVG Volume (30 Days)
- REPL 8.7M
- SCVL 364.9K
- Earning Date
- REPL 11-07-2025
- SCVL 11-20-2025
- Dividend Yield
- REPL N/A
- SCVL 3.31%
- EPS Growth
- REPL N/A
- SCVL N/A
- EPS
- REPL N/A
- SCVL 2.27
- Revenue
- REPL N/A
- SCVL $1,153,927,000.00
- Revenue This Year
- REPL N/A
- SCVL N/A
- Revenue Next Year
- REPL N/A
- SCVL $2.07
- P/E Ratio
- REPL N/A
- SCVL $7.98
- Revenue Growth
- REPL N/A
- SCVL N/A
- 52 Week Low
- REPL $2.68
- SCVL $16.14
- 52 Week High
- REPL $17.00
- SCVL $39.29
- Technical
- Relative Strength Index (RSI)
- REPL 76.27
- SCVL 31.60
- Support Level
- REPL $7.69
- SCVL $19.45
- Resistance Level
- REPL $10.85
- SCVL $19.48
- Average True Range (ATR)
- REPL 0.70
- SCVL 0.61
- MACD
- REPL 0.43
- SCVL -0.12
- Stochastic Oscillator
- REPL 89.86
- SCVL 7.24
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.